Skip to main content

Advertisement

SpringerLink
Log in

Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers

  • Original Article
  • Published:
Tumor Biology

Abstract

Predicting lymph node metastasis (LNM) accurately is very important to decide treatment strategies preoperatively. The aim of this study was to explore risk factors that predict the presence of LNM in early gastric cancer (EGC). A total of 230 patients with EGC who underwent curative gastrectomy with lymph adenectomy at Xinhua Hospital from January 2006 to July 2014 were retrospectively reviewed. We studied the relationship between clinicopathological factors, biological markers (p53, ki67, nm23, vascular endothelial growth factor (VEGF), epidermal growth factor receptor (EGFR), E-cadherin (E-cad), beta-catenin (b-catenin), glutathione S-transferase (GST), and topoisomerase II (Topo II)), and LNM of EGC patients by chi-square test and logistic regression analysis. Meta-analyses were further conducted to review the effects of the proteins (P53, ki67, E-cad, and b-catenin) on LNM in ECG patients. LNM was detected in 42 (18.3 %) of 230 patients. Incidences of LNM was distinct in different tumor size (p = 0.044), depth of submucosal invasion (p < 0.0001), and P53 overexpression (p = 0.004). Multivariate analysis further indentified that large tumor size (≥20 mm, odds ratio (OR) = 2.168, p = 0.041), submucosa (OR = 4.000, p = 0.0005), and P53 overexpression (OR = 3.010, p = 0.022) were independent risk factors of LNM in EGC patients. The meta-analysis revealed a significantly statistical association of P53, ki67, and b-catenin with an increased risk of LNM in EGC patients (P53, OR = 1.81, p = 0.017; ki67, OR = 2.53, p = 0.0003; b-catenin, OR = 0.53, p = 0.01). Tumor size (≥20 mm), the depth of invasion (submucosa), and P53 overexpression may be helpful predictors of LNM in EGC patients. Furthermore, the results of meta-analysis revealed that P53, ki67 overexpression, and abnormal expression of b-catenin may be associated with LNM in EGC. The results need further validation in single large studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kajitani T. The general rules for the gastric cancer study in surgery and pathology. Part I. Clinical classification. Jpn J Surg. 1981;11:127–39.

    Article  CAS  PubMed  Google Scholar 

  2. Wu CY, Chen JT, Chen GH, Yeh HZ. Lymph node metastasis in early gastric cancer: a clinicopathological analysis. Hepatogastroenterology. 2002;49:1465–8.

    PubMed  Google Scholar 

  3. Mouri R, Yoshida S, Tanaka S, Oka S, Yoshihara M, Chayama K. Usefulness of endoscopic ultrasonography in determining the depth of invasion and indication for endoscopic treatment of early gastric cancer. J Clin Gastroenterol. 2009;43:318–22.

    Article  PubMed  Google Scholar 

  4. Boku T, Nakane Y, Okusa T, Hirozane N, Imabayashi N, Hioki K, et al. Strategy for lymphadenectomy of gastric cancer. Surgery. 1989;105:585–92.

    CAS  PubMed  Google Scholar 

  5. Popiela T, Kulig J, Kolodziejczyk P, Sierzega M. Long-term results of surgery for early gastric cancer. Br J Surg. 2002;89:1035–42.

    Article  CAS  PubMed  Google Scholar 

  6. Seto Y, Shimoyama S, Kitayama J, Mafune K, Kaminishi M, Aikou T, et al. Lymph node metastasis and preoperative diagnosis of depth of invasion in early gastric cancer. Gastric Cancer. 2001;4:34–8.

    Article  CAS  PubMed  Google Scholar 

  7. Ren G, Cai R, Zhang WJ, Ou JM, Jin YN, Li WH. Prediction of risk factors for lymph node metastasis in early gastric cancer. World J Gastroenterol. 2013;19:3096–107.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Noh SH, Hyung WJ, Cheong JH. Minimally invasive treatment for gastric cancer: approaches and selection process. J Surg Oncol. 2005;90:188–94.

    Article  PubMed  Google Scholar 

  9. Shin N, Jeon TY, Kim GH, Park DY. Unveiling lymph node metastasis in early gastric cancer. World J Gastroenterol. 2014;20:5389–95.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Ono H, Kondo H, Gotoda T, Shirao K, Yamaguchi H, Saito D, et al. Endoscopic mucosal resection for treatment of early gastric cancer. Gut. 2001;48:225–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Gotoda T, Yamamoto H, Soetikno RM. Endoscopic submucosal dissection of early gastric cancer. J Gastroenterol. 2006;41:929–42.

    Article  PubMed  Google Scholar 

  12. Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A. TP53 and gastric carcinoma: a review. Hum Mutat. 2003;21:258–70.

    Article  CAS  PubMed  Google Scholar 

  13. Xiangming C, Hokita S, Natsugoe S, Tanabe G, Baba M, Takao S, et al. Cooccurrence of reduced expression of alpha-catenin and overexpression of p53 is a predictor of lymph node metastasis in early gastric cancer. Oncology-Basel. 1999;57:131–7.

    Article  CAS  Google Scholar 

  14. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol. 1984;133:1710–5.

    CAS  PubMed  Google Scholar 

  15. Weigel MT, Dowsett M. Current and emerging biomarkers in breast cancer: prognosis and prediction. Endocr Relat Cancer. 2010;17:R245–62.

    Article  CAS  PubMed  Google Scholar 

  16. Backer JM, Mendola CE, Kovesdi I, Fairhurst JL, O’Hara B, Eddy RJ, et al. Chromosomal localization and nucleoside diphosphate kinase activity of human metastasis-suppressor genes NM23-1 and NM23-2. Oncogene. 1993;8:497–502.

    CAS  PubMed  Google Scholar 

  17. Radovic S, Doric M, Hukic A, Babic M, Kuskunovic S, Spahovic N. Immunohistochemical expression and significance of NM23 suppressor protein in primary gastric adenocarcinoma. Bosn J Basic Med Sci. 2013;13:72–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JE, Liotta LA, et al. Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst. 1988;80:200–4.

    Article  CAS  PubMed  Google Scholar 

  19. Lieto E, Ferraraccio F, Orditura M, Castellano P, Mura AL, Pinto M, et al. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients. Ann Surg Oncol. 2008;15:69–79.

    Article  PubMed  Google Scholar 

  20. Jin EH, Lee DH, Jung SA, Shim KN, Seo JY, Kim N, et al. Clinicopathologic factors and molecular markers related to lymph node metastasis in early gastric cancer. World J Gastroenterol. 2015;21:571–7.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J. 1989;8:1711–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Ozawa M, Ringwald M, Kemler R. Uvomorulin-catenin complex formation is regulated by a specific domain in the cytoplasmic region of the cell adhesion molecule. Proc Natl Acad Sci U S A. 1990;87:4246–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Ozawa M, Kemler R. Molecular organization of the uvomorulin-catenin complex. J Cell Biol. 1992;116:989–96.

    Article  CAS  PubMed  Google Scholar 

  24. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol. 1991;113:173–85.

    Article  CAS  PubMed  Google Scholar 

  25. Vleminckx K, Vakaet LJ, Mareel M, Fiers W, van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell. 1991;66:107–19.

    Article  CAS  PubMed  Google Scholar 

  26. Geng M, Wang L, Chen X, Cao R, Li P. The association between chemosensitivity and Pgp. GST-pi and Topo II expression in gastric cancer. Diagn Pathol. 2013;8:198.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Japanese GCA. Japanese classification of gastric carcinoma - 2nd English edition -. Gastric Cancer. 1998;1:10–24.

    Article  Google Scholar 

  28. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.

  29. Hu B, El HN, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: classification, histology and application of molecular pathology. J Gastrointest Oncol. 2012;3:251–61.

    PubMed  PubMed Central  Google Scholar 

  30. Tanaka M, Kitajima Y, Edakuni G, Sato S, Miyazaki K. Abnormal expression of E-cadherin and beta-catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastric cancer. Br J Surg. 2002;89:236–44.

    CAS  PubMed  Google Scholar 

  31. Nagatsuma AK, Aizawa M, Kuwata T, Doi T, Ohtsu A, Fujii H, et al. Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma. Gastric Cancer. 2015;18:227–38.

    Article  CAS  PubMed  Google Scholar 

  32. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  33. MANTEL N, HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.

    CAS  PubMed  Google Scholar 

  34. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Maehara Y, Orita H, Okuyama T, Moriguchi S, Tsujitani S, Korenaga D, et al. Predictors of lymph node metastasis in early gastric cancer. Br J Surg. 1992;79:245–7.

    Article  CAS  PubMed  Google Scholar 

  36. Gotoda T. Endoscopic resection of early gastric cancer. Gastric Cancer. 2007;10:1–11.

    Article  PubMed  Google Scholar 

  37. Tong JH, Sun Z, Wang ZN, Zhao YH, Huang BJ, Li K, et al. Early gastric cancer with signet-ring cell histologic type: risk factors of lymph node metastasis and indications of endoscopic surgery. Surgery. 2011;149:356–63.

    Article  PubMed  Google Scholar 

  38. Lim MS, Lee HW, Im H, Kim BS, Lee MY, Jeon JY, et al. Predictable factors for lymph node metastasis in early gastric cancer-analysis of single institutional experience. J Gastrointest Surg. 2011;15:1783–8.

    Article  PubMed  Google Scholar 

  39. Guadagni S, Reed PI, Johnston BJ, De Bernardinis G, Catarci M, Valenti M, et al. Early gastric cancer: follow-up after gastrectomy in 159 patients. Br J Surg. 1993;80:325–8.

    Article  CAS  PubMed  Google Scholar 

  40. Adachi Y, Yasuda K, Inomata M, Shiraishi N, Kitano S, Sugimachi K. Clinicopathologic study of early-stage mucinous gastric carcinoma. Cancer. 2001;91:698–703.

    Article  CAS  PubMed  Google Scholar 

  41. Ohashi S, Okamura S, Urano F, Maeda M. Clinicopathological variables associated with lymph node metastasis in submucosal invasive gastric cancer. Gastric Cancer. 2007;10:241–50.

    Article  PubMed  Google Scholar 

  42. Kwee RM, Kwee TC. Predicting lymph node status in early gastric cancer. Gastric Cancer. 2008;11:134–48.

    Article  PubMed  Google Scholar 

  43. Carson DA, Lois A. Cancer progression and p53. Lancet. 1995;346:1009–11.

    Article  CAS  PubMed  Google Scholar 

  44. Chang F, Syrjanen S, Syrjanen K. Implications of the p53 tumor-suppressor gene in clinical oncology. J Clin Oncol. 1995;13:1009–22.

    Article  CAS  PubMed  Google Scholar 

  45. Zheng Y, Wang L, Zhang JP, Yang JY, Zhao ZM, Zhang XY. Expression of p53, c-erbB-2 and Ki67 in intestinal metaplasia and gastric carcinoma. World J Gastroenterol. 2010;16:339–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Sasaki O, Kido K, Nagahama S. DNA ploidy, Ki-67 and p53 as indicators of lymph node metastasis in early gastric carcinoma. Anal Quant Cytol Histol. 1999;21:85–8.

    CAS  PubMed  Google Scholar 

  47. Kanai T, Konno H, Maruyama K, Baba M, Tanaka T, Maruo Y, et al. P53 overexpression and proliferative activity do not correlate with lymph node metastasis in early gastric cancer. Eur Surg Res. 1997;29:35–41.

    Article  CAS  PubMed  Google Scholar 

  48. Jiaqing L, Hokita S, Xiangming C, Natsugoe S, Tanabe G, Baba M, et al. Role of cyclin E and p53 expression in progression of early gastric cancer. Gastric Cancer. 1998;1:160–5.

    Article  PubMed  Google Scholar 

  49. Goncalves AR, Carneiro AJ, Martins I, de Faria PA, Ferreira MA, de Mello EL, et al. Prognostic significance of p53 protein expression in early gastric cancer. Pathol Oncol Res. 2011;17:349–55.

    Article  CAS  PubMed  Google Scholar 

  50. Goishi H, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G, et al. Predictive value of Cathepsin D and Ki-67 expression at the deepest penetration site for lymph node metastases in gastric cancer. Oncol Rep. 2000;7:713–8.

    CAS  PubMed  Google Scholar 

  51. Cai J, Ikeguchi M, Tsujitani S, Maeta M, Liu J, Kaibara N. Significant correlation between micrometastasis in the lymph nodes and reduced expression of E-cadherin in early gastric cancer. Gastric Cancer. 2001;4:66–74.

    Article  CAS  PubMed  Google Scholar 

  52. Yoshii T, Miyagi Y, Nakamura Y, Kobayashi O, Kameda Y, Ohkawa S. Pilot research for the correlation between the expression pattern of E-cadherin-beta-catenin complex and lymph node metastasis in early gastric cancer. Tumori. 2013;99:234–8.

    CAS  PubMed  Google Scholar 

  53. Blok P, Craanen ME, Dekker W, Tytgat GN. Loss of E-cadherin expression in early gastric cancer. Histopathology. 1999;34:410–5.

    Article  CAS  PubMed  Google Scholar 

  54. Shun CT, Wu MS, Lin MT, Chang MC, Lin JT, Chuang SM. Immunohistochemical evaluation of cadherin and catenin expression in early gastric carcinomas: correlation with clinicopathologic characteristics and helicobacter pylori infection. Oncology-Basel. 2001;60:339–45.

    Article  CAS  Google Scholar 

  55. Yi KD, Kyoon JJ, Kyu PY, Yeob RS, Soo KH, Kyun NB, et al. E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis. J Surg Oncol. 2007;96:429–35.

    Article  Google Scholar 

  56. Joo YE, Rew JS, Choi SK, Bom HS, Park CS, Kim SJ. Expression of e-cadherin and catenins in early gastric cancer. J Clin Gastroenterol. 2002;35:35–42.

    Article  PubMed  Google Scholar 

  57. Xiangming C, Hokita S, Nuruki K, Toyoyama H, Tanabe G, Baba M, et al. The expression of cadherin-catenin complex in association with the clinicopathologic features of early gastric cancer. Surg Today. 1998;28:587–94.

    Article  CAS  PubMed  Google Scholar 

  58. Chen C, Yang JM, Hu TT, Xu TJ, Yan G, Hu SL, et al. Prognostic role of human epidermal growth factor receptor in gastric cancer: a systematic review and meta-analysis. Arch Med Res. 2013;44:380–9.

    Article  CAS  PubMed  Google Scholar 

  59. Galizia G, Lieto E, Orditura M, Castellano P, Mura AL, Imperatore V, et al. Epidermal growth factor receptor (EGFR) expression is associated with a worse prognosis in gastric cancer patients undergoing curative surgery. World J Surg. 2007;31:1458–68.

    Article  PubMed  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department of Oncology, Xin Hua Hospital affiliated to Shanghai Jiaotong University School of Medicine, NO.1665, Kong Jiang Road, Shanghai, 200092, People’s Republic of China

      Yi-Wei Wang, Mei-Ling Zhu, Wen-Ji Xue, Xue-Ru Zhu & Lei-Zhen Zheng

    2. Department of Pathology, Xin Hua Hospital affiliated to Shanghai Jiaotong University School of Medicine, NO.1665, Kong Jiang Road, Shanghai, 200092, People’s Republic of China

      Rui-Fen Wang & Li-Feng Wang

    Authors
    1. Yi-Wei Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Mei-Ling Zhu
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Rui-Fen Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Wen-Ji Xue
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Xue-Ru Zhu
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Li-Feng Wang
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Lei-Zhen Zheng
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding authors

    Correspondence to Li-Feng Wang or Lei-Zhen Zheng.

    Ethics declarations

    Conflicts of interest

    None

    Additional information

    Yi-Wei Wang and Mei-Ling Zhu contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Wang, YW., Zhu, ML., Wang, RF. et al. Predictable factors for lymph node metastasis in early gastric cancer analysis of clinicopathologic factors and biological markers. Tumor Biol. 37, 8567–8578 (2016). https://doi.org/10.1007/s13277-015-4721-3

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s13277-015-4721-3

    Keywords

    Search

    Navigation